Literature DB >> 17507653

Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle.

Kelly J Perkins1, Utpal Basu, Murat T Budak, Caroline Ketterer, Santhosh M Baby, Olga Lozynska, John A Lunde, Bernard J Jasmin, Neal A Rubinstein, Tejvir S Khurana.   

Abstract

Utrophin is the autosomal homologue of dystrophin, the protein product of the Duchenne's muscular dystrophy (DMD) locus. Utrophin expression is temporally and spatially regulated being developmentally down-regulated perinatally and enriched at neuromuscular junctions (NMJs) in adult muscle. Synaptic localization of utrophin occurs in part by heregulin-mediated extracellular signal-regulated kinase (ERK)-phosphorylation, leading to binding of GABPalpha/beta to the N-box/EBS and activation of the major utrophin promoter-A expressed in myofibers. However, molecular mechanisms contributing to concurrent extrasynaptic silencing that must occur to achieve NMJ localization are unknown. We demonstrate that the Ets-2 repressor factor (ERF) represses extrasynaptic utrophin-A in muscle. Gel shift and chromatin immunoprecipitation studies demonstrated physical association of ERF with the utrophin-A promoter N-box/EBS site. ERF overexpression repressed utrophin-A promoter activity; conversely, small interfering RNA-mediated ERF knockdown enhanced promoter activity as well as endogenous utrophin mRNA levels in cultured muscle cells in vitro. Laser-capture microscopy of tibialis anterior NMJ and extrasynaptic transcriptomes and gene transfer studies provide spatial and direct evidence, respectively, for ERF-mediated utrophin repression in vivo. Together, these studies suggest "repressing repressors" as a potential strategy for achieving utrophin up-regulation in DMD, and they provide a model for utrophin-A regulation in muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507653      PMCID: PMC1949368          DOI: 10.1091/mbc.e06-12-1069

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  53 in total

1.  CoREST: a functional corepressor required for regulation of neural-specific gene expression.

Authors:  M E Andrés; C Burger; M J Peral-Rubio; E Battaglioli; M E Anderson; J Grimes; J Dallman; N Ballas; G Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Expression of the utrophin gene during myogenic differentiation.

Authors:  A O Gramolini; B J Jasmin
Journal:  Nucleic Acids Res       Date:  1999-09-01       Impact factor: 16.971

3.  Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.

Authors:  L Le Gallic; D Sgouras; G Beal; G Mavrothalassitis
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

4.  Implication of a multisubunit Ets-related transcription factor in synaptic expression of the nicotinic acetylcholine receptor.

Authors:  L Schaeffer; N Duclert; M Huchet-Dymanus; J P Changeux
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

5.  A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy.

Authors:  E A Burton; J M Tinsley; P J Holzfeind; N R Rodrigues; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta.

Authors:  T S Khurana; A G Rosmarin; J Shang; T O Krag; S Das; S Gammeltoft
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

7.  Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles.

Authors:  R Gilbert; J Nalbantoglu; B J Petrof; S Ebihara; G H Guibinga; J M Tinsley; A Kamen; B Massie; K E Davies; G Karpati
Journal:  Hum Gene Ther       Date:  1999-05-20       Impact factor: 5.695

8.  Discordant expression of utrophin and its transcript in human and mouse skeletal muscles.

Authors:  A O Gramolini; G Karpati; B J Jasmin
Journal:  J Neuropathol Exp Neurol       Date:  1999-03       Impact factor: 3.685

9.  M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity.

Authors:  Stéphanie Gobert Gosse; Caroline Bourgin; Wang Qing Liu; Christiane Garbay; Guy Mouchiroud
Journal:  Cell Signal       Date:  2005-03-23       Impact factor: 4.315

10.  Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein.

Authors:  A O Gramolini; L M Angus; L Schaeffer; E A Burton; J M Tinsley; K E Davies; J P Changeux; B J Jasmin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

View more
  7 in total

1.  Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

Authors:  Guy L Odom; Paul Gregorevic; James M Allen; Eric Finn; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

2.  Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors:  Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

3.  Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.

Authors:  Theresa J Kannanayakal; Jerry R Mendell; Jeff Kuret
Journal:  Neurosci Lett       Date:  2007-12-15       Impact factor: 3.046

4.  Translational regulation of utrophin by miRNAs.

Authors:  Utpal Basu; Olga Lozynska; Catherine Moorwood; Gopal Patel; Steve D Wilton; Tejvir S Khurana
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

5.  The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.

Authors:  Simon Guiraud; Benjamin Edwards; Arran Babbs; Sarah E Squire; Adam Berg; Lee Moir; Matthew J Wood; Kay E Davies
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

6.  UtroUp is a novel six zinc finger artificial transcription factor that recognises 18 base pairs of the utrophin promoter and efficiently drives utrophin upregulation.

Authors:  Annalisa Onori; Cinzia Pisani; Georgios Strimpakos; Lucia Monaco; Elisabetta Mattei; Claudio Passananti; Nicoletta Corbi
Journal:  BMC Mol Biol       Date:  2013-01-30       Impact factor: 2.946

7.  Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice.

Authors:  Georgios Strimpakos; Nicoletta Corbi; Cinzia Pisani; Maria Grazia Di Certo; Annalisa Onori; Siro Luvisetto; Cinzia Severini; Francesca Gabanella; Lucia Monaco; Elisabetta Mattei; Claudio Passananti
Journal:  J Cell Physiol       Date:  2014-09       Impact factor: 6.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.